Billerica, MA 1/7/10; San Diego, CA 1/12/10; San Francisco, CA 1/13/10; Hopkinton, MA 1/14/10—Three instrument companies have announced preliminary revenue guidance for the fourth quarter of 2009. Illumina stated that it expects fourth-quarter sales of $176 million, compared to earlier guidance of minimum sales of $165 million. As a result, 2009 revenues are expected to grow 15% to $662 million, according to the company. Illumina estimated that 2010 revenues would increase 20% and non-GAAP EPS would be $0.90–$1.00. The company expects 2010 gross margins to be in the mid to high 60s. According to its presentation at the J.P. Morgan Healthcare Conference, Bruker expects fourth-quarter revenues of more than $340 million. The company had not previously provided guidance for the quarter. Last year, Bruker reported fourth-quarter revenues of $315.2 million. Bruker announced earlier this month that in the second half of 2009, it had received system orders of more than $70 million related to global stimulus funding. Caliper Life Sciences announced that it expects fourth-quarter revenues of $37.6 million, compared to earlier guidance of $33–$35 million, due to stronger-than-anticipated sales of IVIS and LabChip products and licensing revenues. In the fourth quarter of 2008, the company posted revenues of $36.7 million. Caliper’s revenues for 2009 are expected to total $130.3 million, or $119.6 million excluding divested operations, compared to 2008 revenues of $134.1 million. Caliper also expects to report positive operating cash flows for the full year, one year ahead of previous guidance.